Plan5500

Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan — Form 5500 plan (Pharmaceutical Research And Manufacturers Of America)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan is a benefit plan reported by Pharmaceutical Research And Manufacturers Of America under EIN 53-0241211 and plan number 002. The latest loaded filing year is 2023. The filing reports 383 participants and $111,681,712 in end-of-year plan assets, where available in the loaded dataset.

Form 5500 plan profile · 2023

Key reported metrics

Net assets (EOY)$111.7MPlan net assets, end of year$111,681,712
Participants383Covered participants reported
Assets / participant$291.6KComputed: assets ÷ participants$291,597 (computed)
Provider compensation$62.2K3 Schedule C provider row(s)$62,182
Plan sponsor
Pharmaceutical Research And Manufacturers Of America
EIN
53-0241211
Plan number
002
Plan type
2
Location
Washington, DC
Latest filing year
2023
How to read this plan profile
  • Net assets = total assets minus total liabilities, end of year (Schedule H/I).
  • Assets / participant is computed (assets ÷ reported participants) — a ratio, not a filed figure.
  • Schedule chips (Sch H / I / C) show which schedules each filing includes.
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • Figures are reported as filed, in whole dollars; verify against the official DOL/EBSA record before relying on them.
EFAST2 filings

Form 5500 filing history

Each loaded annual filing for this plan. Open one for its full reported snapshot.

  1. 2023
    383 participants · 2Sch HSch C
    View filing →
Schedule H · 2023

Reported financial statement

Reported figures as filed, in whole dollars. Only fields the filing reports are shown; others are marked not reported.

Reported balance (end of year)$111.7M total assets
Net assets$111.7MLiabilities$0
Money in vs. money out
Total income / additions$28M
Total expenses$11.4M
Benefits paid / distributions$11.4M
Contributions
Employer$5.3M
Participant$4.2M
Full reported line items

Net assets

Total assets (EOY)
$111,681,712
Total liabilities (EOY)
$0
Net assets (EOY)
$111,681,712
Net assets (BOY)
$95,096,938

Income & contributions

Employer contributions
$5,321,552
Participant contributions
$4,223,655
Total contributions
$10,367,031
Total income / additions
$27,987,179

Expenses & distributions

Benefits paid
$11,377,521
Administrative expenses
$24,884
Total expenses
$11,402,405
Net increase / (decrease)
$16,584,774
Computed from reported fields

Reported ratios

Derived only from this plan's own reported figures — comparisons within the filing, not benchmarks, estimates, or national averages.

Contribution share (employer vs. participant)
Employer 56%Participant 44%
Total expenses ÷ net assets10%Computed ratio
Benefits paid ÷ total income41%Computed ratio
Provider comp. ÷ net assets0%Computed ratio
Schedule C

Service provider compensation

Reported direct + indirect compensation per provider, ranked. Bars show relative scale.

  1. 1
    Global Retirement Partners LLC$38.2K
    INVESTMENT ADVISORY · Direct $38.2K
  2. 2
    Principal Life Insurance Company$21.9K
    CONTRACT ADMINISTRATOR · Direct $21.9K · Indirect $0
  3. 3
    Prudential Retirement Insurance And$2K
    NONE · Direct $2K

What to inspect next

Frequently asked questions

Who sponsors the Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan?
Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan is reported as sponsored by Pharmaceutical Research And Manufacturers Of America (EIN 53-0241211, plan number 002) in public Form 5500 filings.
What is the most recent Form 5500 filing year for Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan?
The latest Form 5500 filing year loaded for Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan is 2023.
How many participants does Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan report?
Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan reports 383 participants in its latest loaded Form 5500 filing.
What are the reported plan assets for Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan?
Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan reports $111,681,712 in end-of-year plan assets in its latest loaded Form 5500 filing.
Form 5500 terms, in plain English
Form 5500
The annual report most U.S. employee benefit plans file with the Department of Labor through the EFAST2 system. It documents the plan sponsor, participants, finances, and service-provider compensation.
Schedule H
The financial statement for larger plans (generally 100+ participants): assets, liabilities, net assets, income, expenses, and the net change.
Schedule I
The condensed financial statement for smaller plans, covering the same kinds of figures in less detail.
Schedule C
Reports compensation paid to the plan’s service providers — both direct and indirect.
Net assets
Total assets minus total liabilities at the end of the year — what the plan holds for participants.
Employer / participant contributions
Money contributed to the plan by the employer and by participants during the year.

Figures are reported as filed and may contain errors or omissions. Verify against the official DOL/EBSA record before relying on any value.

Related Form 5500 pages